Analyst Consensus
- Current Price
- 91.70 $
- Target (Low)
- 84.00 $
- Target (Mean)
- 116.16 $
- Target (High)
- 137.00 $
- Recommendation
- Buy
- Number of Analysts
- 19
Recommendation Distribution
Recommendation Distribution| Strong Buy | 7 |
|---|
| Buy | 11 |
|---|
| Hold | 2 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 38.0%
- Operating Margin
- 49.4%
- Gross Margin
- 97.5%
- Return on Equity (ROE)
- 19.1%
- Return on Assets (ROA)
- 2.0%
- Revenue Growth
- 15.8%
- Earnings Growth
- 38.6%
- Debt/Equity
- 120.77
- Current Ratio
- 0.63
- Beta
- 0.77
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 15, 2026 | Raymond James | Outperform → Outperform |
| May 15, 2026 | TD Cowen | Buy → Buy |
| May 15, 2026 | Piper Sandler | Neutral → Neutral |
| May 15, 2026 | Barclays | Overweight → Overweight |
| Apr 17, 2026 | JP Morgan | Overweight → Overweight |
| Apr 17, 2026 | Morgan Stanley | Overweight → Overweight |